Global Dialysis - Shire Announces Launch Of FOSRENOL(R) In Japan - Management Of Hyperphosphataemia In End-Stage Renal Disease Patients (Medical News Today)

Shire Announces Launch Of FOSRENOL(R) In Japan - Management Of Hyperphosphataemia In End-Stage Renal Disease Patients (Medical News Today)

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announces the Japanese launch of FOSRENOL(R) (lanthanum carbonate), which is now available to prescribers and patients in Japan through Shire's strategic alliance partner Bayer Yakuhin Ltd.